Photo of Robert Z. Orlowski from faculty.mdanderson.org
Dec 11, 2024, 12:41
Robert Orlowski on patients with newly diagnosed multiple myeloma to benefit from Isa-VRd as initiation therapy
MD Anderson Cancer Center shared on X:
“Patients with newly diagnosed multiple myeloma may benefit from Isa-VRd as initiation therapy, our Dr. Robert Orlowski reported at ASH24 to an audience spilling over into three overflow rooms.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 6, 2025, 01:21
May 6, 2025, 00:26
May 5, 2025, 17:25
May 5, 2025, 16:58